Pinnacle Associates’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-65,823
| Closed | -$270K | – | 804 |
|
|
2022
Q1 | $270K | Hold |
65,823
| – | – | ﹤0.01% | 694 |
|
|
2021
Q4 | $235K | Hold |
65,823
| – | – | ﹤0.01% | 728 |
|
|
2021
Q3 | $240K | Hold |
65,823
| – | – | ﹤0.01% | 692 |
|
|
2021
Q2 | $287K | Sell |
65,823
-850
| -1% | -$3.71K | 0.01% | 655 |
|
|
2021
Q1 | $274K | Hold |
66,673
| – | – | 0.01% | 640 |
|
|
2020
Q4 | $266K | Hold |
66,673
| – | – | 0.01% | 621 |
|
|
2020
Q3 | $180K | Buy |
66,673
+1,000
| +2% | +$2.7K | ﹤0.01% | 645 |
|
|
2020
Q2 | $181K | Sell |
65,673
-18,732
| -22% | -$51.6K | ﹤0.01% | 641 |
|
|
2020
Q1 | $199K | Buy |
84,405
+36,615
| +77% | +$86.3K | 0.01% | 608 |
|
|
2019
Q4 | $225K | Sell |
47,790
-12,450
| -21% | -$58.6K | ﹤0.01% | 643 |
|
|
2019
Q3 | $202K | Hold |
60,240
| – | – | ﹤0.01% | 664 |
|
|
2019
Q2 | $198K | Buy |
+60,240
| New | +$198K | ﹤0.01% | 672 |
|